LIMNW — LIMINATUS PHARMA INC.
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 25 SEC-registered investment managers reported holding LIMNW (LIMINATUS PHARMA INC.) in their latest 13F filings, with a combined reported value of $421.27K across 1.80M shares. That is -2.4% by share count (-43.00K shares) versus the previous quarter, while reported value moved +413.8%. Ownership is concentrated: the five largest holders account for 87.7% of reported value and the top ten for 94.3%.
Compared with the prior quarter, 2 opened new positions, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of LIMINATUS PHARMA INC. (LIMNW) include DUPONT CAPITAL MANAGEMENT CORP, CANTOR FITZGERALD, L. P., ARISTEIA CAPITAL, L.L.C., ranked by reported 13F value among the 33 institutional holders on this page.
LIMNW is classified in the Materials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 9 | 282.54K | $355.83K | -0.2% |
| Q2 2026 | 25 | 1.80M | $421.27K | -2.4% |
| Q1 2026 | 24 | 1.81M | $81.55K | -31.7% |
| Q4 2025 | 27 | 2.83M | $102.83K | +0.6% |
| Q3 2025 | 29 | 2.99M | $428.88K | -1.4% |
| Q2 2025 | 27 | 2.97M | $694.06K | — |
Over the 6 quarters shown, institutional share counts decreased 90% in aggregate (Q2 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (-31.7%).
Top Institutional Holders (Q3 2026) — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.25K | $341.00K | 0.02% | Hold | |
| 111.75K | $6.20K | 0.00% | Hold | |
| 50.00K | $2.00K | 0.00% | Hold | |
| 30.00K | $1.67K | 0.00% | Hold | |
| 29.17K | $1.62K | 0.00% | Hold | |
| 24.13K | $1.34K | 0.00% | Reduce | |
| 13.11K | $1.00K | 0.00% | Hold | |
| 13.98K | $776 | 0.00% | Hold | |
| 4.16K | $233 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.25K | $318.00K | 0.01% | Hold | |
| 319.51K | $16.28K | 0.00% | Hold | |
| 268.20K | $13.68K | 0.00% | Hold | |
| 233.76K | $11.91K | 0.00% | Hold | |
| 125.00K | $9.38K | 0.00% | Hold | |
| 111.75K | $8.38K | 0.00% | Hold | |
| 122.69K | $6.26K | 0.00% | Hold | |
| 70.62K | $5.30K | 0.00% | Hold | |
| 70.62K | $5.30K | 0.00% | Hold | |
| 83.35K | $2.93K | 0.00% | Hold | |
| 83.35K | $2.93K | 0.00% | Hold | |
| 35.10K | $2.63K | 0.00% | Hold | |
| 29.96K | $2.25K | 0.00% | Hold | |
| 29.17K | $2.19K | 0.00% | Hold | |
| 50.00K | $2.00K | 0.00% | Hold | |
| 30.00K | $1.98K | 0.00% | Reduce | |
| 24.27K | $1.82K | 0.00% | Hold | |
| 22.56K | $1.69K | 0.00% | Hold | |
| 20.93K | $1.57K | 0.00% | Hold | |
| 17.56K | $1.32K | 0.00% | New | |
| 13.98K | $1.05K | 0.00% | Reduce | |
| 13.11K | $1.00K | 0.00% | Hold | |
| 10.80K | $1.00K | 0.00% | New | |
| 4.51K | $338 | 0.00% | Hold | |
| 1.25K | $94 | 0.00% | Hold |
Q1 2026 — 24 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 319.51K | $15.66K | 0.00% | Hold | |
| 268.20K | $13.14K | 0.00% | Hold | |
| 233.76K | $11.45K | 0.00% | Hold | |
| 122.69K | $6.01K | 0.00% | Hold | |
| 125.00K | $5.00K | 0.00% | Hold | |
| 111.75K | $4.47K | 0.00% | Hold | |
| 83.35K | $3.33K | 0.00% | Hold | |
| 83.35K | $3.33K | 0.00% | Hold | |
| 70.62K | $2.83K | 0.00% | Hold | |
| 70.62K | $2.83K | 0.00% | Hold | |
| 50.00K | $2.00K | 0.00% | Hold | |
| 47.50K | $1.90K | 0.00% | Hold | |
| 39.37K | $1.57K | 0.00% | Reduce | |
| 35.10K | $1.40K | 0.00% | Hold | |
| 29.96K | $1.20K | 0.00% | Hold | |
| 29.17K | $1.17K | 0.00% | Hold | |
| 13.11K | $1.00K | 0.00% | New | |
| 24.27K | $971 | 0.00% | Hold | |
| 22.56K | $902 | 0.00% | Hold | |
| 21.03K | $841 | 0.00% | Reduce | |
| 6.25K | $306 | 0.00% | Hold | |
| 4.51K | $180 | 0.00% | Add | |
| 1.25K | $50 | 0.00% | Hold | |
| 100 | $4 | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 805.18K | $28.18K | 0.00% | Hold | |
| 319.51K | $12.22K | 0.00% | Hold | |
| 268.20K | $10.59K | 0.00% | Hold | |
| 233.76K | $8.94K | 0.00% | Hold | |
| 158.47K | $5.55K | 0.00% | Add | |
| 122.69K | $4.69K | 0.00% | Hold | |
| 125.00K | $4.38K | 0.00% | Hold | |
| 111.75K | $3.91K | 0.00% | Hold | |
| 83.35K | $2.92K | 0.00% | Hold | |
| 83.35K | $2.92K | 0.00% | Hold | |
| 70.62K | $2.47K | 0.00% | Hold | |
| 70.62K | $2.47K | 0.00% | Hold | |
| 62.80K | $2.20K | 0.00% | Hold | |
| 50.00K | $2.00K | 0.00% | Hold | |
| 47.50K | $1.73K | 0.00% | Hold | |
| 35.10K | $1.23K | 0.00% | Hold | |
| 29.96K | $1.05K | 0.00% | Hold | |
| 29.70K | $1.04K | 0.00% | Reduce | |
| 29.17K | $1.02K | 0.00% | Hold | |
| 24.27K | $850 | 0.00% | Reduce | |
| 23.91K | $837 | 0.00% | New | |
| 22.56K | $790 | 0.00% | Hold | |
| 12.40K | $434 | 0.00% | New | |
| 6.25K | $219 | 0.00% | Hold | |
| 4.21K | $147 | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 805.38K | $119.11K | 0.00% | New | |
| 319.51K | $47.27K | 0.00% | Add | |
| 268.20K | $39.69K | 0.00% | Hold | |
| 233.76K | $34.59K | 0.00% | Hold | |
| 125.00K | $18.49K | 0.00% | Hold | |
| 122.69K | $18.16K | 0.00% | Hold | |
| 144.43K | $17.33K | 0.00% | Add | |
| 111.75K | $16.53K | 0.00% | Hold | |
| 97.33K | $11.68K | 0.00% | New | |
| 89.10K | $10.69K | 0.00% | Hold | |
| 70.62K | $10.44K | 0.00% | Hold | |
| 70.62K | $10.44K | 0.00% | Hold | |
| 83.35K | $10.00K | 0.00% | Hold | |
| 83.35K | $10.00K | 0.00% | Hold | |
| 62.86K | $9.30K | 0.00% | Reduce | |
| 50.00K | $7.39K | 0.00% | Hold | |
| 47.50K | $7.03K | 0.00% | Reduce | |
| 35.10K | $5.20K | 0.00% | Hold | |
| 30.00K | $4.44K | 0.00% | New | |
| 29.96K | $4.43K | 0.00% | Hold | |
| 29.17K | $4.32K | 0.00% | Hold | |
| 24.43K | $3.61K | 0.00% | Reduce | |
| 22.56K | $3.34K | 0.00% | Hold | |
| 15.00K | $2.22K | 0.00% | Hold | |
| 13.11K | $2.00K | 0.00% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 875.82K | $210.11K | 0.01% | New | |
| 313.24K | $67.35K | 0.00% | New | |
| 268.20K | $56.32K | 0.01% | New | |
| 233.76K | $56.08K | 0.00% | New | |
| 133.86K | $32.50K | 0.00% | New | |
| 125.00K | $30.35K | 0.00% | New | |
| 111.75K | $26.81K | 0.00% | New | |
| 122.69K | $26.38K | 0.00% | New | |
| 102.99K | $24.71K | 0.00% | New | |
| 89.10K | $21.63K | 0.00% | New | |
| 83.35K | $20.24K | 0.00% | New | |
| 83.35K | $20.24K | 0.00% | New | |
| 70.62K | $16.94K | 0.00% | New | |
| 70.62K | $16.94K | 0.00% | New | |
| 50.00K | $11.99K | 0.00% | New | |
| 50.00K | $11.99K | 0.00% | New | |
| 35.20K | $8.44K | 0.00% | New | |
| 29.96K | $7.19K | 0.00% | New | |
| 29.17K | $7.00K | 0.01% | New | |
| 26.94K | $6.46K | 0.00% | New | |
| 22.56K | $5.41K | 0.00% | New | |
| 15.00K | $3.60K | 0.00% | New | |
| 13.11K | $3.00K | 0.00% | New | |
| 6.25K | $1.52K | 0.00% | New | |
| 2.02K | $485 | 0.00% | New |
New Positions (Q2 2026)
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 17.56K sh · $1.32K
- Virtu Financial LLC 10.80K sh · $1.00K
Fully Exited (vs previous quarter)
- Clear Street Group Inc. sold 100 sh · $4
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| DUPONT CAPITAL MANAGEMENT CORP | 6.25K | 6.25K | 6.25K | 6.25K | 6.25K | 6.25K |
| MMCAP International Inc. SPC | 111.75K | 111.75K | 111.75K | 111.75K | 111.75K | 111.75K |
| Blue Owl Capital Holdings LP | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
| PERISCOPE CAPITAL INC. | 30.00K | 30.00K | 47.50K | 47.50K | 47.50K | 50.00K |
| Arena Capital Advisors, LLC- CA | 29.17K | 29.17K | 29.17K | 29.17K | 29.17K | 29.17K |
| JANE STREET GROUP, LLC | 24.13K | 24.27K | 24.27K | 24.27K | 24.43K | 26.94K |
| FLOW TRADERS U.S. LLC | 13.11K | 13.11K | 13.11K | — | 13.11K | 13.11K |
| WOLVERINE ASSET MANAGEMENT LLC | 13.98K | 13.98K | 39.37K | 62.80K | 62.86K | 102.99K |
| UBS Group AG | 4.16K | 4.51K | 4.51K | 4.21K | 290 | 2.02K |
| CANTOR FITZGERALD, L. P. | — | — | — | — | — | 875.82K |
| Clear Street Group Inc. | — | — | 100 | 805.18K | 805.38K | — |
| ARISTEIA CAPITAL, L.L.C. | — | 319.51K | 319.51K | 319.51K | 319.51K | 313.24K |
| LINDEN ADVISORS LP | — | 268.20K | 268.20K | 268.20K | 268.20K | 268.20K |
| Saba Capital Management, L.P. | — | 233.76K | 233.76K | 233.76K | 233.76K | 233.76K |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | — | — | 158.47K | 144.43K | 133.86K |
| Moore Capital Management | — | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K |
| Polar Asset Management Partners Inc. | — | 122.69K | 122.69K | 122.69K | 122.69K | 122.69K |
| Alpha Wave Global, LP | — | — | — | — | 89.10K | 89.10K |
| D. E. Shaw & Co., Inc. | — | 83.35K | 83.35K | 83.35K | 83.35K | 83.35K |
| MILLENNIUM MANAGEMENT LLC | — | 70.62K | 70.62K | 70.62K | 70.62K | 70.62K |
FAQ
Which funds hold LIMNW?
As of 2026-Q2, 25 institutional funds reported holding LIMNW (LIMINATUS PHARMA INC.) in SEC 13F filings, with a combined reported value of $421.27K.
How many shares of LIMNW do institutions own?
13F filers reported 1.80M shares of LIMNW, worth $421.27K in aggregate at the end of 2026-Q2.
Is institutional ownership of LIMNW rising or falling?
Share counts moved -2.4% versus the prior quarter — distribution.
Who are the top institutional holders of LIMNW?
The largest 13F holders are DUPONT CAPITAL MANAGEMENT CORP, CANTOR FITZGERALD, L. P., ARISTEIA CAPITAL, L.L.C., LINDEN ADVISORS LP, Saba Capital Management, L.P.; the top 25 are ranked at the top of this page.
Who are the major shareholders of LIMINATUS PHARMA INC.?
The major shareholders of LIMINATUS PHARMA INC. (LIMNW) by reported 13F value are DUPONT CAPITAL MANAGEMENT CORP, CANTOR FITZGERALD, L. P., ARISTEIA CAPITAL, L.L.C., LINDEN ADVISORS LP, Saba Capital Management, L.P., among 33 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.